Indivior (LON:INDV) Shares Down 15.7% – Should You Sell?

Indivior PLC (LON:INDV) fell 15.7% during mid-day trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 732 ($9.25). 1,888,371 shares were traded during trading, an increase of 166% from the average session volume of 709,477 shares. The stock had previously closed at GBX 868 ($10.97).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “buy” rating and set a GBX 1,800 ($22.74) target price on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06. The business’s 50 day moving average price is GBX 920.11 and its 200-day moving average price is GBX 850.81. The company has a market cap of £1.08 billion, a price-to-earnings ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.